---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-230711"
form_type: "8-K"
ticker: "GRTX"
cik: "0001563577"
company_name: "Galera Therapeutics, Inc."
filed_at: "2026-05-19T20:01:45+00:00"
generated_at: "2026-05-19T20:05:10.412388+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Galera Therapeutics converts all Series B Preferred Stock into 42.8M common shares

## Summary
- Converted 42,839.11 Series B preferred shares into 42,839,103 common shares on May 15, 2026.
- No fractional shares were issued; holders will receive cash in lieu of fractional shares.
- After conversion, no shares of Series B Preferred Stock remain outstanding.

## SEC filing metadata
- accession: 0001193125-26-230711
- form_type: 8-K
- ticker: GRTX
- cik: 0001563577
- company_name: Galera Therapeutics, Inc.
- filed_at: 2026-05-19T20:01:45+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1563577/000119312526230711/0001193125-26-230711-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1563577/000119312526230711/d78370d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-230711
- JSON: https://secwatch.observer/filing/0001193125-26-230711.json
- Plain text: https://secwatch.observer/filing/0001193125-26-230711.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.